New antibiotic cresomycin combats antibiotic-resistant bacteria effectively

ft.com

Scientists have developed a new antibiotic, cresomycin, which effectively combats antibiotic-resistant bacteria in non-human tests. The drug is more potent than its predecessors and has shown promise in combating dangerous bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. This breakthrough is crucial in the fight against antimicrobial resistance, which is linked to 5 million deaths annually. Roche is conducting phase 1 clinical trials on a similar antibiotic.


With a significance score of 6.8, this news ranks in the top 0.1% of today's 29880 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


New antibiotic cresomycin combats antibiotic-resistant bacteria effectively | News Minimalist